Immunotherapies strengthen the body's own anticancer defenses in a highly targeted manner. In therapies using so-called CAR T cells (chimeric antigen receptor T cells), a patient's immune cells are genetically engineered and directed against individual cancer cells. Until now, it has remained unclear why even very low…
Число случаев рака в мире вырастет на две трети к 2050 году, предупредили ученые gazeta.press
Researchers from Cambridge and Basel have developed small molecules that could make cancer immunotherapies more effective. They work in two ways: they prompt macrophages to engulf cancer cells and alter the surrounding tissue, reducing its ability to suppress immune attacks on the tumor.
Sumanta K. Pal: Misalignment Between Clinical Trial Access and Disease Burden in US Bladder Cancer Oncodaily
Oncotarget supports WIN 2026 Symposium advancing precision oncology EurekAlert!
Физическая активность и диеты снижают побочные эффекты лечения рака простаты на треть Vademec.ru
Exercise and wellbeing programme reduces side effects of prostate cancer treatment, study finds The Pharmaceutical Journal
Amgen claims win for Imdelltra in maintenance lung cancer setting FirstWord PHARMA
Petros Grivas: New Research Highlights Gaps in Cancer Clinical Trial Availability Oncodaily
Lung Cancer Treatment May Become More Adaptive With a Simple Blood Test SurvivorNet
«Все чисто»: Симоньян сообщила результаты обследования на рак Zerkalo
Каждый час без движения приближает финал: ученые из Глазго обнаружили критическую связь с раком Правда.Ру
Ismail Siala: Looking Back on the First Tripoli Cancer Center Oncology Conference Oncodaily
2025/26 in review: Cancer Research UK drives major progress against cancer Cancer Research UK - Cancer News
«Все чисто». Маргарита Симоньян – о своем излечении от рака Новости Краснодара и Краснодарского края